Finance

Lists
Q1 2027 earnings • in 2 days
See details
METROPOLIS:NSE
Metropolis Healthcare Ltd
₹580.70
-0.77%
(-4.50) 1D
Jul 31, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for METROPOLIS...
Open
₹585.20
High
₹586.15
Low
₹567.60
Mkt. cap
120.78B
Avg. vol.
309.74K
Volume
324.21K
Dividend
0.52%
Quarterly dividend
₹0.75
Ex-dividend date
May 19, 2026
P/E ratio
63.19
52-wk high
₹609.05
52-wk low
₹412.25
EPS
₹9.19
No. of employees
4K
Open
₹585.20
High
₹586.15
Low
₹567.60
Mkt. cap
120.78B
Avg. vol.
309.74K
Volume
324.21K
Dividend
0.52%
Quarterly dividend
₹0.75
Ex-dividend date
May 19, 2026
P/E ratio
63.19
52-wk high
₹609.05
52-wk low
₹412.25
EPS
₹9.19
No. of employees
4K
News stories
From sources across the web
Profile
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019. Wikipedia
About Metropolis Healthcare Ltd
CEOVijender Singh
Employees4.48K
Founded1980
Headquarters-
SectorHealth care provider
Websitemetropolisindia.com
Next call in 2 days
Wed, Aug 5, 5:30 AM
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ₹2.65
Revenue / Est. (INR)
- / 4.46B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.86B
4.29B
4.06B
4.25B
Cost of goods sold
790.49M
877.48M
792.37M
1.27B
Cost of revenue
790.49M
877.48M
792.37M
1.27B
Research and development expenses
56.74M
49.67M
80.57M
43.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
922.79M
953.93M
942.25M
2.92B
Operating expense
2.48B
2.66B
2.64B
2.28B
Total operating expenses
3.27B
3.53B
3.43B
3.55B
Operating income
589.12M
758.17M
629.68M
701.16M
Other non operating income
75.16M
8.91M
90.16M
-64.72M
EBT including unusual items
612.30M
710.26M
571.57M
697.63M
EBT excluding unusual items
612.30M
710.26M
662.53M
663.07M
Income tax expense
159.85M
181.36M
150.70M
188.03M
Effective tax rate
26.11%
25.53%
26.37%
26.95%
Other operating expenses
1.19B
1.33B
1.30B
-1.07B
Net income
450.61M
526.68M
413.86M
509.03M
Net profit margin
11.67%
12.27%
10.20%
11.99%
Earnings per share
2.16
2.53
2.31
2.46
Interest and investment income
-
-
-
38.12M
Interest expense
-51.98M
-56.82M
-57.30M
-79.33M
Net interest expenses
-51.98M
-56.82M
-57.30M
-41.21M
Depreciation and amortization charges
308.45M
324.08M
318.78M
385.90M
EBITDA
640.18M
1.07B
680.74M
774.79M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps